Rocket Pharmaceuticals (RCKT) insider trading in the last 6 months
5 insiders sold $743K. No buys.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at Rocket Pharmaceuticals
Questions about RCKT's insider trades
Are RCKT insiders buying or selling?
5 insiders sold $743K across 12 filings in the last 6 months. No open-market buys on record. The newest filing: Martin Wilson, General Counsel, sold $128K on Nov 5, 2026.
Who are RCKT's biggest insider sellers?
By the dollars of their sales in the last 6 months: Martin Wilson (General Counsel), 5 sales; Gaurav Shah (CEO), 4 sales; Christopher James Stevens (Chief Operating Officer), 1 sale. 5 insiders sold in all.
When did an RCKT insider last buy?
No RCKT insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Martin Wilson on Nov 5, 2026.
Rocket Pharmaceuticals's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.